Continuous biomanufacturing is mature enough to use commercially for a range of products, manufacturing scales, and global geographies. That’s the conclusion of Sarfaraz Niazi, PhD, adjunct professor ...

The ability to turn cells into miniature drug plants has revolutionized medicine, allowing developers to create better targeted and more effective therapies for a broader range of diseases. But ...

SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced today that it has ...

The biopharmaceutical industry is transitioning towards continuous biomanufacturing processes that require advanced analytical tools to monitor and control bioprocesses to produce high-quality ...

Process analytical technology in biomanufacturing has undergone a fundamental transformation over the past two decades, moving quality control from the analytical laboratory to the manufacturing floor ...

Pow.Bio announced its $9.5 million Series A round. Re:Food and Thia Ventures led the round and were joined by Hitachi Ventures - the strategic corporate venture capital arm of Hitachi, Ltd. - with ...

A team of uOttawa Faculty of Medicine researchers have developed a path to a biomanufacturing process that could potentially transform how Canada generates immunotherapeutic materials—specifically ...

Running a thousand virtual scale-up simulations before touching a single real-world valve is no longer a theoretical ambition. Digital twins in biomanufacturing have matured from concept to ...

CRB’s Horizons: Life Sciences 2025 report finds 50% of large life-science firms accelerating U.S. capital projects and 65% adopting continuous-manufacturing systems as tariffs and FDA restructuring ...

The process of biomanufacturing requires engineering microbes to produce useful chemicals and materials from carbon neutral processes. But current biomanufacturing cannot get beyond small production ...

Armies of microscopic single-celled microbial food factories (yeast, bacteria, fungi, algae) are now routinely deployed to produce high-value food ingredients more efficiently than plants or animals.

Pow.Bio’s technology advantage includes the first ever AI-controlled, automated fermentation platform The raise is helping Pow.Bio to expand operations with a state of the art demonstration plant in ...